Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy

Gynecologic Oncology

Volumn 104, Issue 3, 2007, Pages 642-646

  Suzuki, Yoshiyuki ^a   Oka, Kuniyuki ^b   Yoshida, Daisaku ^a   Shirai, Katsuyuki ^a   Ohno, Tatsuya ^c   Kato, Shingo ^c   Tsujii, Hirohiko ^c   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Mito Saiseikai General Hospital   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Cervix; Cytoplasmic; Radiation therapy; Squamous cell; Survivin

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 33846921574     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.10.005     Document Type: Article

References (28)

1. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
2. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (1997) 917-921
3. Weinman E.C., Roche P.C., Kasperbauer J.L., Cha S.S., Sargent D.J., Cheville J., et al. Characterization of antigen processing machinery and survivin expression in tonsillar squamous cell carcinoma. Cancer 97 (2003) 2203-2211
4. Shariat S.F., Lotan Y., Saboorian H., Khoddami S.M., Roehrborn C.G., Slawin K.M., et al. Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer 100 (2004) 751-757
5. Saxena A., Yashar C., Taylor D.D., and Gercel-Taylor C. Cellular response to chemotherapy and radiation in cervical cancer. Am. J. Obstet. Gynecol. 192 (2005) 1399-1403
6. Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Rubini C., Mariggio M.A., et al. Survivin expression in oral squamous cell carcinoma. Br. J. Cancer 89 (2003) 2244-2248
7. Rodel F., Hoffmann J., Distel L., Herrmann M., Noisternig T., Papadopoulos T., et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res. 65 (2005) 4881-4887
8. Kami K., Doi R., Koizumi M., Toyoda E., Mori T., Ito D., et al. Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery 136 (2004) 443-448
9. Lee J.P., Chang K.H., Han J.H., and Ryu H.S. Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors. Int. J. Gynecol. Cancer 15 (2005) 113-119
10. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in carcinoma of the uterus, vagina and ovary. Radiumhemmet, Sweden vol. 16 (1979), FIGO
11. Poulsen H.E., Taylor C.W., and Sobin L.H. Histological typing of female genital tract tumors (1975), World Health Organization, Geneva, Switzerland [No. 13]
12. Arai T., Nakano T., Morita S., Sakashita K., Nakamura Y.K., and Fukuhisa K. High dose rate remote after-loading intracavitary radiation therapy for cancer of the uterine cervix. Cancer 69 (1992) 175-180
13. Fortugno P., Wall N.R., Giodini A., O'Connor D.S., Plescia J., Padgett K.M., et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. 115 (2002) 575-585
14. Grabowski P., Kuhnel T., Muhr-Wilkenshoff F., Heine B., Stein H., Hopfner M., et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 88 (2003) 115-119
15. Okada E., Murai Y., Matsui K., Isizawa S., Cheng C., Masuda M., et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 163 (2001) 109-116
16. Tonini G., Vincenzi B., Santini D., Scarpa S., Vasaturo T., Malacrino C., et al. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. Br. J. Cancer 92 (2005) 2225-2232
17. Kennedy S.M., O'Driscoll L., Purcell R., Fitz-Simons N., McDermott E.W., Hill A.D., et al. Prognostic importance of survivin in breast cancer. Br. J. Cancer 88 (2003) 1077-1083
18. Islam A., Kageyama H., Hashizume K., Kaneko Y., and Nakagawara A. Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med. Pediatr. Oncol. 35 (2000) 550-553
19. Fangusaro J.R., Jiang Y., Holloway M.P., Caldas H., Singh V., Boue D.R., et al. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome. Br. J. Cancer 92 (2005) 359-365
20. Altura R.A., Olshefski R.S., Jiang Y., and Boue D.R. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br. J. Cancer 89 (2003) 1743-1749
21. Shinohara E.T., Gonzalez A., Massion P.P., Chen H., Li M., Freyer A.S., et al. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 103 (2005) 1685-1692
22. Yamada Y., Kuroiwa T., Nakagawa T., Kajimoto Y., Dohi T., Azuma H., et al. Transcriptional expression of survivin and its splice variants in brain tumors in humans. J. Neurosurg. 99 (2003) 738-745
23. Saitoh Y., Yaginuma Y., and Ishikawa M. Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int. J. Oncol. 15 (1999) 137-141
24. Kim H.S., Shiraki K., and Park S.H. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res. 22 (2002) 805-808
25. Frost M., Jarboe E.A., Orlicky D., Gianani R., Thompson L.C., Enomoto T., et al. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am. J. Clin. Pathol. 117 (2002) 738-744
26. Yoshida H., Sumi T., Hyun Y., Nakagawa E., Hattori K., Yasui T., et al. Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Oncol. Rep. 10 (2003) 45-49
27. Chakravarti A., Zhai G.G., Zhang M., Malhotra R., Latham D.E., Delaney M.A., et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23 (2004) 7494-7506
28. Lu B., Mu Y., Cao C., Schneider S., Tan J., Price J., et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res. 64 (2004) 2840-2845